跳至主要内容
临床试验/JPRN-jRCTs051180049
JPRN-jRCTs051180049已完成1 期

Efficacy and safety of greenpropolis against prostate cancer with biochemical recurrence after radical prostatectomy - Efficacy and safety of greenpropolis against prostate cancer

Kobayashi Takashi0 个研究点目标入组 22 人开始时间: 2019年2月5日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
22

研究概览

简要总结

There was no significant anticancer response in patients who received Brazilian green propolis for biochemical recurrence after radical prostatectomy. However, the PSA slope was decreased after propolis administration. Further, Brazilian green propolis may be safely consumed by patients without any related allergies.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 <= 84age old(—)
性别
Male

入选标准

  • Adults younger than 85 years, histologically confirmed adenocarcinoma of the prostate cancer with PSA recurrence (PSA>= 0.2 ng/ml, 2 rising PSA tests with >= at least 2-week interval between each determination ) after radical prostatectomy including patients after salvage radiation therapy to prostatic bed; no prior or present evidence of metastatic disease; ECOG 0~2; no surgery or radiation allowed within 4 weeks before day 1.

排除标准

  • Previously treated or currently be receiving hormonal therapy with the intent to treat prostate cancer (surgical castration or other hormonal manipulation, e.g. GnRH agonists or antagonists, anti-androgens or estrogens); Evidence of administration of greenpropolis or other alternative therapies within 3 months before day 1. History of allergy against honey, a coniferous tree, a poplar, Peru balsam, and salicylic acid; History of atopic dermatitis, chronic recurrent eczema, and asthma

研究者

相似试验